Septic TLR9−/− mice exhibited lower inflammatory cytokines release and higher survival compared with wild-type mice, indicating that inhibition of TLR9 is a potential therapeutic strategy for sepsis [5]. This evidence concerns the gene TLR9 and Sepsis.